Annual Total Expenses
$8.37 M
-$7.72 M-47.97%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual total expenses is $8.37 million, with the most recent change of -$7.72 million (-47.97%) on December 31, 2023.
- During the last 3 years, ABVC annual total expenses has fallen by -$619.90 thousand (-6.90%).
- ABVC annual total expenses is now -47.97% below its all-time high of $16.08 million, reached on December 31, 2022.
Performance
ABVC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$339.30 K
-$754.50 K-68.98%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly total expenses is $339.30 thousand, with the most recent change of -$754.50 thousand (-68.98%) on September 30, 2024.
- Over the past year, ABVC quarterly total expenses has dropped by -$1.83 million (-84.37%).
- ABVC quarterly total expenses is now -94.87% below its all-time high of $6.61 million, reached on March 31, 2016.
Performance
ABVC Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ABVC Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.0% | -84.4% |
| 3 y3 years | -6.9% | -82.5% |
| 5 y5 years | +500.5% | -82.5% |
ABVC Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.0% | at low | -94.6% | at low |
| 5 y | 5-year | -48.0% | +101.2% | -94.6% | at low |
| alltime | all time | -48.0% | >+9999.0% | -94.9% | +113.6% |
ABVC BioPharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $339.30 K(-69.0%) |
| Jun 2024 | - | $1.09 M(-68.3%) |
| Mar 2024 | - | $3.45 M(+75.5%) |
| Dec 2023 | $8.37 M(-48.0%) | $1.96 M(-9.5%) |
| Sep 2023 | - | $2.17 M(-1.3%) |
| Jun 2023 | - | $2.20 M(+8.1%) |
| Mar 2023 | - | $2.03 M(-45.3%) |
| Dec 2022 | $16.08 M(+37.5%) | $3.72 M(-1.0%) |
| Sep 2022 | - | $3.76 M(+59.3%) |
| Jun 2022 | - | $2.36 M(-62.2%) |
| Mar 2022 | - | $6.24 M(-1.0%) |
| Dec 2021 | $11.70 M(+30.2%) | $6.31 M(+225.5%) |
| Sep 2021 | - | $1.94 M(-6.3%) |
| Jun 2021 | - | $2.07 M(+48.5%) |
| Mar 2021 | - | $1.39 M(-71.7%) |
| Dec 2020 | $8.99 M(+116.1%) | $4.91 M(+249.6%) |
| Sep 2020 | - | $1.41 M(-1.1%) |
| Jun 2020 | - | $1.42 M(+13.6%) |
| Mar 2020 | - | $1.25 M(+2.2%) |
| Dec 2019 | $4.16 M(+198.5%) | $1.22 M(-6.8%) |
| Sep 2019 | - | $1.31 M(+93.0%) |
| Jun 2019 | - | $680.60 K(-27.8%) |
| Mar 2019 | - | $942.80 K(-559.2%) |
| Dec 2018 | $1.39 M(-66.3%) | -$205.30 K(-151.7%) |
| Sep 2018 | - | $397.00 K(-24.8%) |
| Jun 2018 | - | $527.70 K(-21.7%) |
| Mar 2018 | - | $674.20 K(+91.1%) |
| Dec 2017 | $4.14 M(+3.6%) | $352.80 K(-89.5%) |
| Sep 2017 | - | $3.36 M(+1672.9%) |
| Sep 2017 | $4.00 M(-63.7%) | - |
| Jun 2017 | - | $189.50 K(-20.0%) |
| Mar 2017 | - | $236.80 K(+12.5%) |
| Dec 2016 | - | $210.40 K(-67.5%) |
| Sep 2016 | $11.00 M(>+9900.0%) | $647.80 K(+124.1%) |
| Jun 2016 | - | $289.10 K(-95.6%) |
| Mar 2016 | - | $6.61 M(+88.7%) |
| Dec 2015 | - | $3.50 M(>+9900.0%) |
| Sep 2015 | $35.60 K(>+9900.0%) | $32.00 K(+2033.3%) |
| Jun 2015 | - | $1500.00(+36.4%) |
| Mar 2015 | - | $1100.00(+10.0%) |
| Dec 2014 | - | $1000.00(>+9900.0%) |
| Sep 2014 | $100.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | $185.00 K(-83.9%) | $0.00(-100.0%) |
| Jun 2013 | - | $19.40 K(-8.5%) |
| Mar 2013 | - | $21.20 K(-85.3%) |
| Dec 2012 | - | $144.50 K(+33.7%) |
| Sep 2012 | $1.15 M(-39.3%) | $108.10 K(-55.9%) |
| Jun 2012 | - | $245.40 K(-26.6%) |
| Mar 2012 | - | $334.20 K(-27.5%) |
| Dec 2011 | - | $461.00 K(+10.4%) |
| Sep 2011 | $1.89 M(-0.7%) | $417.60 K(-46.0%) |
| Jun 2011 | - | $773.40 K(+134.8%) |
| Mar 2011 | - | $329.40 K(-11.1%) |
| Dec 2010 | - | $370.60 K(+8.0%) |
| Sep 2010 | $1.90 M(-61.2%) | $343.30 K(+0.5%) |
| Jun 2010 | - | $341.70 K(-20.6%) |
| Mar 2010 | - | $430.60 K(-45.4%) |
| Dec 2009 | - | $788.60 K(+3.9%) |
| Sep 2009 | $4.91 M(-8.7%) | $758.90 K(+10.4%) |
| Jun 2009 | - | $687.70 K(-17.6%) |
| Mar 2009 | - | $834.30 K(-68.3%) |
| Dec 2008 | - | $2.63 M(+148.5%) |
| Sep 2008 | $5.38 M(+20.7%) | $1.06 M(-19.5%) |
| Jun 2008 | - | $1.32 M(-15.3%) |
| Mar 2008 | - | $1.55 M(+6.9%) |
| Dec 2007 | - | $1.45 M(+138.2%) |
| Sep 2007 | $4.46 M(>+9900.0%) | - |
| Jun 2007 | - | $610.20 K(+4943.0%) |
| Mar 2007 | - | $12.10 K(-100.5%) |
| Dec 2006 | $26.80 K(+52.3%) | -$2.49 M(-280.1%) |
| Sep 2006 | - | $1.38 M(>+9900.0%) |
| Jun 2006 | - | $7600.00(-8.4%) |
| Mar 2006 | - | $8300.00(-1760.0%) |
| Dec 2005 | $17.60 K(+20.5%) | -$500.00(-107.6%) |
| Sep 2005 | - | $6600.00(+61.0%) |
| Jun 2005 | - | $4100.00(-43.8%) |
| Mar 2005 | - | $7300.00(-122.5%) |
| Dec 2004 | $14.60 K(-61.1%) | -$32.40 K(-195.3%) |
| Sep 2004 | - | $34.00 K(+365.8%) |
| Jun 2004 | - | $7300.00(+28.1%) |
| Mar 2004 | - | $5700.00 |
| Dec 2003 | $37.50 K | - |
FAQ
- What is ABVC BioPharma annual total expenses?
- What is the all time high annual total expenses for ABVC BioPharma?
- What is ABVC BioPharma annual total expenses year-on-year change?
- What is ABVC BioPharma quarterly total expenses?
- What is the all time high quarterly total expenses for ABVC BioPharma?
- What is ABVC BioPharma quarterly total expenses year-on-year change?
What is ABVC BioPharma annual total expenses?
The current annual total expenses of ABVC is $8.37 M
What is the all time high annual total expenses for ABVC BioPharma?
ABVC BioPharma all-time high annual total expenses is $16.08 M
What is ABVC BioPharma annual total expenses year-on-year change?
Over the past year, ABVC annual total expenses has changed by -$7.72 M (-47.97%)
What is ABVC BioPharma quarterly total expenses?
The current quarterly total expenses of ABVC is $339.30 K
What is the all time high quarterly total expenses for ABVC BioPharma?
ABVC BioPharma all-time high quarterly total expenses is $6.61 M
What is ABVC BioPharma quarterly total expenses year-on-year change?
Over the past year, ABVC quarterly total expenses has changed by -$1.83 M (-84.37%)